We are live on
!
Find out more
Los Angeles Capital Management Portfolio holdings
AUM
$25.4B
1-Year Est. Return
38.46%
This Fund
S&P 500
This Quarter
Est. Return
-3.12%
1 Year Est. Return
+38.46%
3 Year Est. Return
+154.38%
5 Year Est. Return
+223.79%
10 Year Est. Return
+923.25%
AUM
$19.3B
AUM Growth
-$1.05B
(-5.2%)
Cap. Flow
-$77.1M
Cap. Flow
% of AUM
-0.4%
Top 10 Holdings %
Top 10 Hldgs %
26.03%
Holding
1,444
New
138
Increased
405
Reduced
531
Closed
234
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$224M |
| 2 |
Brown-Forman Class B
BF.B
|
+$140M |
| 3 |
UnitedHealth
UNH
|
+$132M |
| 4 |
Monolithic Power Systems
MPWR
|
+$108M |
| 5 |
Oracle
ORCL
|
+$97.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$134M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
| 3 |
Micron Technology
MU
|
+$122M |
| 4 |
Pfizer
PFE
|
+$120M |
| 5 |
Microsoft
MSFT
|
+$117M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.43% |
| 2 | Healthcare | 14.49% |
| 3 | Financials | 11.62% |
| 4 | Consumer Discretionary | 10.92% |
| 5 | Industrials | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Mueller Industries
MLI
$15.1B
| $4.54M | 0.02% |
305,344
-81,172
| -21% | -$1.26M |
|
377
Simpson Manufacturing
SSD
$7.99B
| $4.51M | 0.02% |
57,497
-5,850
| -9% | -$566K |
|
378
RTX Corp
RTX
$300B
| $4.5M | 0.02% |
54,961
-35,300
| -39% | -$3.2M |
|
379
Sylvamo
SLVM
$1.53B
| $4.49M | 0.02% |
132,322
-1,574
| -1% | -$59.7K |
|
|
MASI
380
DELISTED
Masimo
MASI
| $4.42M | 0.02% |
+31,300
| New | +$4.57M |
|
|
SFBS
381
ServisFirst Bancshares
SFBS
$4.95B
| $4.38M | 0.02% |
54,782
+22,803
| +71% | +$1.92M |
|
382
ZTO Express
ZTO
$17.6B
| $4.33M | 0.02% |
180,157
+74,755
| +71% | +$1.95M |
|
383
Welltower
WELL
$166B
| $4.29M | 0.02% |
66,623
+52,916
| +386% | +$4.14M |
|
384
Royal Gold
RGLD
$19.7B
| $4.28M | 0.02% |
45,663
| – | – |
|
|
AIRC
385
DELISTED
Apartment Income REIT Corp.
AIRC
| $4.23M | 0.02% |
109,584
-13,220
| -11% | -$560K |
|
386
Medtronic
MDT
$116B
| $4.22M | 0.02% |
52,317
-51,266
| -49% | -$4.61M |
|
387
STAAR Surgical
STAA
$1.27B
| $4.22M | 0.02% |
59,766
-1,502
| -2% | -$129K |
|
388
Thor Industries
THO
$4.11B
| $4.19M | 0.02% |
59,811
+4,963
| +9% | +$406K |
|
389
Airbnb
ABNB
$108B
| $4.17M | 0.02% |
39,708
-745
| -2% | -$82.6K |
|
390
Onto Innovation
ONTO
$20.6B
| $4.12M | 0.02% |
64,366
+256
| +0.4% | +$18.8K |
|
391
Huntsman Corp
HUN
$1.78B
| $4.06M | 0.02% |
165,368
-535,684
| -76% | -$15.1M |
|
392
Mondelez International
MDLZ
$79.4B
| $4.05M | 0.02% |
73,906
+10,160
| +16% | +$631K |
|
393
FirstEnergy
FE
$27.2B
| $4.04M | 0.02% |
109,201
-7,781
| -7% | -$307K |
|
394
Cencora
COR
$60B
| $3.91M | 0.02% |
28,880
-73,450
| -72% | -$10.5M |
|
395
Agilon Health
AGL
$1.45B
| $3.88M | 0.02% |
6,618
+2,269
| +52% | +$1.36M |
|
396
The Ensign Group
ENSG
$10.6B
| $3.87M | 0.02% |
48,730
+7,885
| +19% | +$652K |
|
397
Calix
CALX
$2.51B
| $3.84M | 0.02% |
+62,855
| New | +$3.36M |
|
398
Iridium Communications
IRDM
$5.26B
| $3.84M | 0.02% |
86,606
+5,115
| +6% | +$222K |
|
|
SGEN
399
DELISTED
Seagen Inc. Common Stock
SGEN
| $3.83M | 0.02% |
+27,980
| New | +$4.56M |
|
400
Chemours
CC
$2.29B
| $3.71M | 0.02% |
150,472
-310,410
| -67% | -$10.2M |
|
Similar funds
VAI
Los Angeles Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, Los Angeles Capital Management held 1,444 positions worth $19.3B, down 5.2% from $20.3B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Los Angeles Capital Management's Q3 2022 filing shows 138 new, 405 increased, 531 reduced and 234 closed positions. Its largest new stake was Neurocrine Biosciences: 791,966 shares worth $84.1M. The largest sale was Alphabet (Google) Class C, an estimated $134M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
- Los Angeles Capital Management's largest Q3 2022 buy was Neurocrine Biosciences: 791,966 shares worth $84.1M.
- Los Angeles Capital Management added most to Broadcom in Q3 2022, an estimated $224M increase.
- Los Angeles Capital Management's biggest Q3 2022 reduction was Alphabet (Google) Class C, cutting an estimated $134M.
- Los Angeles Capital Management fully exited D.R. Horton in Q3 2022, selling an estimated $37.1M.
- Los Angeles Capital Management's ten largest holdings make up 26% of its $19.3B portfolio in Q3 2022.
- Los Angeles Capital Management opened 138 new positions and closed 234 in Q3 2022.
- Los Angeles Capital Management's portfolio value fell 5.2% quarter-over-quarter to $19.3B.
Based on Los Angeles Capital Management's 13F filing for Q3 2022, filed 2 Nov 2022.